To validate the expression patterns of TAM receptors (MERTK and AXL) and their ligands (GAS6 and PROS1) across various tumor stages, multiple immunofluorescence assays were conducted (Figure 5A, Figure S4A). Here, MERTK is linked to neoplasm.